DEERFIELD MANAGEMENT COMPANY, L.P. Q3 2022 Filing
Filed November 14, 2022
Portfolio Value
$5.0B
Holdings
130
Report Date
Q3 2022
Filing Type
13F-HR
All Holdings (130 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | NUVLNUVALENT INC | 19,341,024 | $376.0B | 7484.26% | |
| 2 | GKOS 2.75 06/15/27GLAUKOS CORP | 271,752,000 | $355.8B | 7083.35% | |
| 3 | —AERIE PHARMACEUTICALS INC | 174,372,000 | $170.8B | 3400.38% | |
| 4 | —INVITAE CORP | 206,873,000 | $162.2B | 3229.03% | |
| 5 | NBIXNEUROCRINE BIOSCIENCES INC | 1,512,714 | $160.7B | 3198.12% | |
| 6 | AHCOADAPTHEALTH CORP | 8,223,536 | $154.4B | 3074.16% | |
| 7 | SRPT 1.5 11/15/24SAREPTA THERAPEUTICS INC | 88,657,000 | $148.3B | 2951.27% | |
| 8 | IONS 0 04/01/26IONIS PHARMACEUTICALS INC | 127,800,000 | $128.5B | 2558.21% | |
| 9 | —TABULA RASA HEALTHCARE INC | 144,516,000 | $115.5B | 2299.74% | |
| 10 | SILKSILK RD MED INC | 2,535,369 | $114.1B | 2271.06% | |
| 11 | —CAREMAX INC | 15,861,090 | $112.5B | 2238.47% | |
| 12 | APLS 3.5 09/15/26APELLIS PHARMACEUTICALS INC | 51,885,000 | $99.1B | 1972.93% | |
| 13 | GILDGILEAD SCIENCES INC | 1,537,539 | $94.9B | 1888.06% | |
| 14 | OPHTEURIVERIC BIO INC | 5,244,098 | $94.1B | 1872.69% | Call |
| 15 | GMED 1 06/01/23NUVASIVE INC | 96,966,000 | $93.7B | 1865.46% | |
| 16 | VTRSVIATRIS INC | 10,673,700 | $90.9B | 1810.21% | |
| 17 | BIIBBIOGEN INC | 330,000 | $88.1B | 1753.87% | |
| 18 | ATEC 0.75 08/01/26ALPHATEC HLDGS INC | 100,000,000 | $81.4B | 1620.90% | |
| 19 | —INTERCEPT PHARMACEUTICALS IN | 78,500,000 | $81.1B | 1614.30% | |
| 20 | PCRX 0.75 08/01/25PACIRA BIOSCIENCES INC | 81,600,000 | $80.8B | 1607.79% | |
| 21 | ACCD 0.5 04/01/26ACCOLADE INC | 105,000,000 | $79.1B | 1574.09% | |
| 22 | AERIEURAERIE PHARMACEUTICALS INC | 4,855,005 | $73.5B | 1462.18% | |
| 23 | INSM 1.75 01/15/25INSMED INC | 75,000,000 | $73.2B | 1457.32% | |
| 24 | IMGNEURIMMUNOGEN INC | 13,740,205 | $65.7B | 1307.35% | |
| 25 | GH 0 11/15/27GUARDANT HEALTH INC | 89,036,000 | $65.0B | 1294.51% | |
| 26 | CPRXCATALYST PHARMACEUTICALS INC | 4,896,000 | $62.8B | 1250.38% | |
| 27 | LUNGPULMONX CORP | 3,720,901 | $62.0B | 1233.94% | |
| 28 | RVMDREVOLUTION MEDICINES INC | 2,891,587 | $57.0B | 1135.05% | |
| 29 | —INTERCEPT PHARMACEUTICALS IN | 57,791,000 | $56.1B | 1116.66% | |
| 30 | LRMRLARIMAR THERAPEUTICS INC | 16,941,357 | $54.2B | 1079.12% | |
| 31 | OSH 0 03/15/26OAK STR HEALTH INC | 68,000,000 | $52.5B | 1044.98% | |
| 32 | NTRA 2.25 05/01/27NATERA INC | 37,638,000 | $51.4B | 1023.10% | |
| 33 | MRUSMERUS N V | 2,521,553 | $50.5B | 1005.37% | |
| 34 | NSTG 2.625 03/01/25NANOSTRING TECHNOLOGIES INC | 57,604,000 | $48.7B | 968.78% | |
| 35 | DCPHEURDECIPHERA PHARMACEUTICALS IN | 2,491,490 | $46.1B | 917.50% | |
| 36 | HLVXHILLEVAX INC | 2,653,231 | $45.3B | 902.59% | |
| 37 | COGTCOGENT BIOSCIENCES INC | 2,966,345 | $44.3B | 880.98% | |
| 38 | EOLSEVOLUS INC | 5,390,103 | $43.4B | 863.70% | |
| 39 | MIRMMIRUM PHARMACEUTICALS INC | 2,032,335 | $42.7B | 849.94% | |
| 40 | TDOC 0.875 06/01/25LIVONGO HEALTH INC | 50,000,000 | $42.0B | 835.57% | |
| 41 | NVRO 2.75 04/01/25NEVRO CORP | 42,000,000 | $39.6B | 788.44% | |
| 42 | CYTKCYTOKINETICS INC | 813,112 | $39.4B | 784.18% | |
| 43 | ONEM 3 06/15/251LIFE HEALTHCARE INC | 40,599,000 | $39.4B | 783.82% | |
| 44 | EWTXEDGEWISE THERAPEUTICS INC | 3,933,137 | $38.7B | 770.38% | |
| 45 | PTCT 1.5 09/15/26PTC THERAPEUTICS INC | 32,000,000 | $37.6B | 747.61% | |
| 46 | ANABANAPTYSBIO INC | 1,466,600 | $37.4B | 744.72% | |
| 47 | B7SBROOKDALE SR LIVING INC | 8,692,561 | $37.1B | 738.83% | |
| 48 | CNCCENTENE CORP DEL | 464,000 | $36.1B | 718.67% | |
| 49 | AMEDAMEDISYS INC | 359,765 | $34.8B | 693.15% | |
| 50 | PHRPHREESIA INC | 1,358,000 | $34.6B | 688.77% | |
| 51 | BLUBELLUS HEALTH INC NEW | 3,081,000 | $32.5B | 647.63% | |
| 52 | KURAKURA ONCOLOGY INC | 2,219,128 | $30.3B | 603.40% | |
| 53 | PHATPHATHOM PHARMACEUTICALS INC | 2,414,897 | $26.8B | 532.61% | |
| 54 | IDYAIDEAYA BIOSCIENCES INC | 1,743,628 | $26.0B | 517.84% | |
| 55 | VERVVERVE THERAPEUTICS INC | 750,000 | $25.8B | 512.83% | |
| 56 | HCAT 2.5 04/15/25HEALTH CATALYST INC | 30,000,000 | $25.5B | 508.25% | |
| 57 | MOHMOLINA HEALTHCARE INC | 75,000 | $24.7B | 492.42% | |
| 58 | NVAX 3.75 02/01/23NOVAVAX INC | 25,000,000 | $24.4B | 485.46% | |
| 59 | SWTXSPRINGWORKS THERAPEUTICS INC | 816,994 | $23.3B | 463.98% | |
| 60 | TARSTARSUS PHARMACEUTICALS INC | 1,324,214 | $22.7B | 451.28% | |
| 61 | ATECALPHATEC HLDGS INC | 2,532,792 | $22.1B | 440.65% | |
| 62 | IM8NINSMED INC | 960,484 | $20.7B | 411.82% | |
| 63 | DAWNDAY ONE BIOPHARMACEUTICALS I | 1,032,000 | $20.7B | 411.47% | |
| 64 | EHABENHABIT INC | 1,454,279 | $20.4B | 406.43% | |
| 65 | VIGLVIGIL NEUROSCIENCE INC | 2,054,794 | $18.0B | 357.32% | |
| 66 | —SINGULAR GENOMICS SYSTEMS IN | 7,078,019 | $17.7B | 352.23% | |
| 67 | XERS 5 07/15/25XERIS BIOPHARMA HOLDINGS INC | 18,000,000 | $17.4B | 346.04% | |
| 68 | TGTXTG THERAPEUTICS INC | 2,677,500 | $15.9B | 315.52% | |
| 69 | —DA32 LIFE SCNCE TEC ACQSTN C | 1,600,000 | $15.6B | 309.89% | |
| 70 | TOITHE ONCOLOGY INSTITUTE INC | 3,360,052 | $15.6B | 309.67% | |
| 71 | PCRXPACIRA BIOSCIENCES INC | 292,000 | $15.5B | 309.15% | |
| 72 | SMFRUSDSEMA4 HOLDINGS CORP | 16,973,488 | $14.9B | 296.47% | |
| 73 | RCKTROCKET PHARMACEUTICALS INC | 870,000 | $13.9B | 276.39% | |
| 74 | ANTXAN2 THERAPEUTICS INC | 716,538 | $12.5B | 247.88% | |
| 75 | KRYSKRYSTAL BIOTECH INC | 175,000 | $12.2B | 242.81% | |
| 76 | PACBPACIFIC BIOSCIENCES CALIF IN | 2,021,000 | $11.7B | 233.53% | |
| 77 | ADCTADC THERAPEUTICS SA | 2,390,297 | $11.5B | 229.33% | |
| 78 | VCELVERICEL CORP | 484,947 | $11.3B | 223.96% | |
| 79 | TERNTERNS PHARMACEUTICALS INC | 1,860,000 | $11.0B | 218.06% | |
| 80 | —EUCRATES BIOMEDICAL ACQUISIT | 999,999 | $10.0B | 199.45% | |
| 81 | —SARISSA CAPITAL ACQUISITN CO | 999,999 | $10.0B | 199.05% | |
| 82 | ALECALECTOR INC | 1,055,192 | $10.0B | 198.70% | |
| 83 | —SENIOR CONNECT ACQUISITN COR | 1,000,000 | $9.9B | 197.96% | |
| 84 | TLSIMEDTECH ACQUISITION CORP | 999,999 | $9.9B | 197.66% | |
| 85 | —REVOLUTION HEALTHCAR AQ CORP | 1,000,000 | $9.8B | 195.47% | |
| 86 | —APOLLO ENDOSURGERY INC | 1,750,000 | $9.6B | 191.95% | |
| 87 | PHVSPHARVARIS N V | 1,104,552 | $8.5B | 168.64% | |
| 88 | —POINT BIOPHARMA GLOBAL INC | 1,000,000 | $7.7B | 153.87% | |
| 89 | —TURMERIC ACQUISITION CORP | 750,000 | $7.5B | 149.29% | |
| 90 | —IGNYTE ACQUISITION CORP | 725,000 | $7.2B | 144.04% | |
| 91 | PEPGPEPGEN INC | 745,293 | $6.8B | 134.70% | |
| 92 | FHTXFOGHORN THERAPEUTICS INC | 777,525 | $6.7B | 132.79% | |
| 93 | INZYINOZYME PHARMA INC | 2,090,436 | $5.6B | 111.51% | |
| 94 | NEO 1.25 05/01/25NEOGENOMICS INC | 6,500,000 | $5.6B | 110.89% | |
| 95 | —GRAYBUG VISION INC | 5,281,713 | $5.0B | 98.87% | |
| 96 | —ORION ACQUISITION CORP | 500,000 | $4.9B | 97.99% | |
| 97 | HOWLWEREWOLF THERAPEUTICS INC | 958,125 | $4.3B | 86.01% | |
| 98 | QSIQUANTUM SI INC | 1,400,000 | $3.9B | 76.64% | |
| 99 | ANNXANNEXON INC | 583,913 | $3.6B | 71.84% | |
| 100 | ORTXUSDORCHARD THERAPEUTICS PLC | 6,949,416 | $3.5B | 69.17% |
Page 1 of 2Next